IBI-Ag: Funding, Investors & Team (Sep 2026)
IBI-Ag is a biotechnology firm that specializes in creating innovative bioinsecticides. Their primary focus is on finding and creating environmentally friendly solutions for insect control using cutting-edge technology. By utilizing advanced methods, IBI-Ag produces effective and safe bio-insect control products that are also cost-efficient for farmers due to their fermentation capabilities.
IBI-Ag has raised $10.0M across 2 funding rounds on record, the most recent a Series A of $3.9M announced in Nov 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
IBI-Ag Company Profile and Key Stats
Latest funding round on record: Nov 2025.
IBI-Ag Funding Rounds
IBI-Ag raised $6.1M in a Series A announced in Feb 2025.
9 months later, a Series A of $3.9M was announced in Nov 2025.
IBI-Ag Founders and Leadership Team
Contact details for the IBI-Ag team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →IBI-Ag Funding Compared to Other Biotechnology Startups
IBI-Ag's latest round of $3.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like IBI-Ag in Biotechnology and Ness Ziona
Companies Similar to IBI-Ag
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
IBI-Ag Funding FAQs
What does IBI-Ag do?
IBI-Ag is a biotechnology firm that specializes in creating innovative bioinsecticides. Their primary focus is on finding and creating environmentally friendly solutions for insect control using cutting-edge technology. By utilizing advanced methods, IBI-Ag produces effective and safe bio-insect control products that are also cost-efficient for farmers due to their fermentation capabilities.
How much funding has IBI-Ag raised?
IBI-Ag has raised $10.0M across 2 rounds on record. The most recent is a Series A of $3.9M announced in Nov 2025.
When did IBI-Ag last raise funding?
IBI-Ag's most recent funding round on record is a Series A of $3.9M, announced in Nov 2025.
Who founded IBI-Ag?
FundedIQ lists Rony Oren Benaroya (Founder) at IBI-Ag.
Where is IBI-Ag headquartered?
IBI-Ag is based in Ness Ziona, Hamerkaz, Israel.
How many employees does IBI-Ag have?
IBI-Ag is in the 1-10 employee band.
How does IBI-Ag's funding compare to other Biotechnology startups?
IBI-Ag's latest round of $3.9M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's IBI-Ag Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IBI-Ag is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.